Adverse reaction reporting


According to Article 18 of Act XCV of 2005 on Medicinal Products for Human Use and Other Laws Regulating the Pharmaceutical Market (the Medicinal Products Act), a healthcare worker is obliged to report suspected adverse reactions that he/she has observed or becomes aware of to the State Pharmaceutical Administration without delay (

If you notice - or are informed of - any unusual symptoms or adverse reactions after taking any of the medicines marketed by MEDITOP Pharmaceutical Ltd:

    •  and via the MEDITOP website applying the registration form below (fill in the fields below and press SEND)

If you do not wish to report to MEDITOP Pharmaceuticals Ltd. using this adverse reaction reporting form, you can find other contact details of the company in the CONTACT menu.

    Data marked with * are required for valid notification by regulatory requirement.

    The notification will be handled in accordance with privacy and data protection rules. The name and contact details of the notifier will be used only for any further data requests related to the clarification of the case and will not be disclosed to third parties (including the pharmaceutical authority).

    The scope of personal data in the case of a notification of a drug reaction is determined by the National Institute of Pharmacy and Nutrition (OGYÉI) on the basis of EMMI Regulation 15/2012 and Article 18 of Act XCV of 2005.

    Thank you for your reporting to help us work towards safer use of our medicines.